Treatment of gastrointestinal stromal tumors

Details for Australian Patent Application No. 2002218262 (hide)

International Classifications

Event Publications

29 September 2005 Application Accepted

Published as AU-B-2002218262

19 January 2006 Amendment Made

The nature of the amendment is: Add co-applicant DanaFaber Cancer Institute, Oregon Health & Science University and The Brigham and Women's Hospital, Inc

2 February 2006 Standard Patent Sealed

16 February 2006 Corrigenda

Amendments, Section 104 - Amendments Made Under the names Novartis AG, Dana-Faber Cancer Institute, The Brigham and Women's Hospital, Inc. and Oregon Health & Science University, Application No. 2002218262, under INID (71) correct the co-applicant name to read Dana-Farber Cancer Institute.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.